Table I

Sequences and masses of the synthetic proteins and peptides used in this study

Proteins and peptides are listed in the order of their appearance in the text. av, average mass, mono, monoisotopic mass.

SequenceMH+Description
MEPVDPRLEPWKHPGSQPKTACTNCYCKKCCF-HCQVCFITKALGISYGRKKRRQRRRPPQGSQT-HQVSLSKQ8346.9 (av)aa 1–72 of HIV-1 Tat
MEPVDPRLEPWKHPGSQPKTACTNCYCKKCCF-HCQVCFITKALGISYGR AcKKRRQRRRPPQGS-QTHQVSLSKQ8388.9 (av)aa 1–72 of HIV-1 Tat, acetylated at Lys50
GGLGISYGRKKRRQRRRP2141.3 (mono)aa 43–58 of HIV-1 Tat (ARM), amino-terminal GG
GGLGISYGRAcKKRRQRRRP2183.3 (mono)aa 43–58 of HIV-1 Tat (ARM), amino-terminal GG, acetylated at Lys50
Biotin-SGRGKGGAcKGLGK1368.7 (mono)aa 1–12 of histone H4, biotinylated, acetylated at Lys8
ISYGRKKRRQRRRP1857.1 (mono)aa 45–58 of HIV-1 Tat (ARM)
ALGISYGRKKRRQRRRP2098.3 (mono)aa 42–58 of HIV-1 Tat (ARM)
ISYGRAKRRQRRRP1801.1 (mono)aa 45–58 of HIV-1 Tat (ARM), K50A exchange
ISYGRKARRQRRRP1801.1 (mono)aa 45–58 of HIV-1 Tat (ARM), K51A exchange
CTNCYCKKCCFHCQ1683.6 (mono)aa 22–35 of HIV-1 Tat (CRR)
LHKSMGRTWQFDYNPEACVIK2523.2 (mono)The 20 proteinogenic aa
LHKSMGRTWQFDYNPEAVIK2420.2 (mono)The 20 proteinogenic aa without cysteine
VCFITKALGISYGRK1655.9 (mono)aa 36–50 of HIV-1 Tat (core)